SciSparc Aktie - SPRC

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,4751

Gebot

0,475

Fragen

0,4751

Volumen

696.869

0,4011 Tagesbereich 0,4961

0,197 52-Wochen-Bereich 6,78

Marktkapitalisierung

1,285M

Handelsende

0,4378

Handelsbeginn

0,4247

Letzte Trade

700

0.4751

(formt)

Letzter Handelszeitpunkt

Finanzvolumen

US$ 307.983

VWAP

0,441953

Durchschnittliches Volumen (3 Mio.)

9.511.035

Ausgegebene Aktien

2.703.674

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,26

Gewinn pro Aktie (EPS)

-1,89

Erlöse

2,88M

Nettogewinn

-5,12M

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The compa... SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority. Mehr anzeigen

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

scisparc.com

Hauptsitz

Tel Aviv, Center, Isr

Gegründet

SciSparc Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRC. The last closing price for SciSparc was US$0,44. Over the last year, SciSparc shares have traded in a share price range of US$ 0,197 to US$ 6,78.

SciSparc currently has 2.703.674 shares in issue. The market capitalisation of SciSparc is US$1,18 million. SciSparc has a price to earnings ratio (PE ratio) of -0.26.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Form POS AM - Post-Effective amendments for registration statement

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

No Immediate Effect on Nasdaq Listing or Trading of the Company’s Ordinary Shares TEL AVIV, Israel, Jan. 15, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a...

SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles

TEL AVIV, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors Ltd., (“AutoMax”), a leading automotive importer and...

SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results

TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

TEL AVIV, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.0427	9.87511563367	0.4324	0.566999	0.4	1656274	0.42278943	CS
4	-0.2294	-32.5621007807	0.7045	0.909	0.4	1302063	0.60095975	CS
12	0.2466	107.921225383	0.2285	1.79	0.197	9511035	0.72352333	CS
26	0.1358	40.0235779546	0.3393	1.79	0.197	5639944	0.6241383	CS
52	-3.4649	-87.9416243655	3.94	6.78	0.197	3301193	0.77144349	CS
156	-129.5249	-99.6345384615	130	181.74	0.197	2215642	10.58037316	CS
260	-181.5249	-99.738956044	182	184.08	0.197	2128422	10.61454583	CS

SPRC - Frequently Asked Questions (FAQ)

What is the current SciSparc share price?

The current share price of SciSparc is US$ 0,4751

How many SciSparc shares are in issue?

SciSparc has 2.703.674 shares in issue

What is the market cap of SciSparc?

The market capitalisation of SciSparc is USD 1,18M

What is the 1 year trading range for SciSparc share price?

SciSparc has traded in the range of US$ 0,197 to US$ 6,78 during the past year

What is the PE ratio of SciSparc?

The price to earnings ratio of SciSparc is -0,26

What is the cash to sales ratio of SciSparc?

The cash to sales ratio of SciSparc is 0,47

What is the reporting currency for SciSparc?

SciSparc reports financial results in USD

What is the latest annual turnover for SciSparc?

The latest annual turnover of SciSparc is USD 2,88M

What is the latest annual profit for SciSparc?

The latest annual profit of SciSparc is USD -5,12M

What is the registered address of SciSparc?

The registered address for SciSparc is 20 RAUL WALLENBERG ST., TOWER A, 2ND FLOOR, TEL AVIV, CENTER, 6971916

What is the SciSparc website address?

The website address for SciSparc is scisparc.com

Which industry sector does SciSparc operate in?

SciSparc operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
MGOLMGO Global Inc	US$ 0,4191 (126,54%)	780,46M
CDTConduit Pharmaceuticals Inc	US$ 2,831 (82,65%)	140,32M
GSIWGarden Stage Ltd	US$ 0,79 (78,73%)	215,16M
TOIIWOncology Institute Inc	US$ 0,033 (58,88%)	7,27k
CYTHCyclo Therapeutics Inc	US$ 1,19 (54,55%)	72,39M
FTELFitell Corporation	US$ 2,70 (-57,01%)	2,28M
SGBXSafe and Green Holdings Corporation	US$ 0,6401 (-44,82%)	5,15M
NKLANikola Corporation	US$ 0,4432 (-41,10%)	47,43M
PLRXPliant Therapeutics Inc	US$ 7,785 (-34,85%)	6,4M
LIPOLipella Pharmaceuticals Inc	US$ 3,08 (-33,76%)	2,08M
MGOLMGO Global Inc	US$ 0,4191 (126,54%)	780,46M
RIMEAlgorhythm Holdings Inc	US$ 0,0169 (-20,66%)	262,79M
GSIWGarden Stage Ltd	US$ 0,79 (78,73%)	215,16M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0537 (14,74%)	210,78M
NVDANVIDIA Corporation	US$ 129,84 (0,90%)	209,04M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

SciSparc Ltd (SPRC) Börsenkurse

SciSparc Ltd (SPRC)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über SciSparc Ltd

SPRC Neueste Nachrichten

SPRC - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen